These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 13555415)

  • 21. Systemic sclerosis and infections.
    Randone SB; Guiducci S; Cerinic MM
    Autoimmun Rev; 2008 Oct; 8(1):36-40. PubMed ID: 18706530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies of the characteristics of the defense mechanisms in anti-viral immunity].
    SMORODINTEV AA
    Stud Cercet Inframicrobiol; 1956; 7(3-4):233-51. PubMed ID: 13455314
    [No Abstract]   [Full Text] [Related]  

  • 23. Specific recognition of virus-infected cells by paired NK receptors.
    Arase H; Lanier LL
    Rev Med Virol; 2004; 14(2):83-93. PubMed ID: 15027001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes.
    Aota N; Shiohara T
    Autoimmun Rev; 2009 May; 8(6):488-94. PubMed ID: 19239928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between human herpesviruses and periodontal disease: Part 1. Herpesviruses immune evasion. A review.
    Feller L; Lemmer J; Meyerov R
    SADJ; 2007 Mar; 62(2):074, 076, 078-9. PubMed ID: 17624177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CD8(+) T cell differentiation in viral infections].
    Bengsch B; Thimme R
    Dtsch Med Wochenschr; 2006 Oct; 131(42):2355-8. PubMed ID: 17043986
    [No Abstract]   [Full Text] [Related]  

  • 27. Innate immunity to respiratory viruses.
    Wang JP; Kurt-Jones EA; Finberg RW
    Cell Microbiol; 2007 Jul; 9(7):1641-6. PubMed ID: 17506818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune control of herpes simplex virus during latency.
    Khanna KM; Lepisto AJ; Decman V; Hendricks RL
    Curr Opin Immunol; 2004 Aug; 16(4):463-9. PubMed ID: 15245740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemphigus and infectious agents.
    Sagi L; Sherer Y; Trau H; Shoenfeld Y
    Autoimmun Rev; 2008 Oct; 8(1):33-5. PubMed ID: 18707028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.
    Pantaleo G; Harari A
    Nat Rev Immunol; 2006 May; 6(5):417-23. PubMed ID: 16622477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs for non-HIV viral infections.
    Treat Guidel Med Lett; 2007 Jul; 5(59):59-70. PubMed ID: 17565338
    [No Abstract]   [Full Text] [Related]  

  • 32. Viral latency and its importance in human disease.
    Tovey MG
    Pathol Biol (Paris); 1980 Dec; 28(10):631-4. PubMed ID: 7007995
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunity and antibodies in viral diseases].
    KOHN A
    Harefuah; 1958 Jun; 54(12):311-4; English & French abstracts 314. PubMed ID: 13562712
    [No Abstract]   [Full Text] [Related]  

  • 34. Virus infections post transplant: risk and immunity.
    Hirsch HH
    Transpl Infect Dis; 2005; 7(3-4):97-8. PubMed ID: 16390396
    [No Abstract]   [Full Text] [Related]  

  • 35. [Passive immunity in poliomyelitis virus infection].
    HAMMON WM
    Minerva Med; 1954 Dec; 45(97):1505. PubMed ID: 13235513
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of immunity in mice after vaccination with inactivated poliomyelitis virus.
    KRECH U
    J Immunol; 1955 Feb; 74(2):117-9. PubMed ID: 14354189
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent developments in new and old viral infections.
    Gentile G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E3. PubMed ID: 16864117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses to viral infections: relevance for asthma.
    Martin JG; Siddiqui S; Hassan M
    Paediatr Respir Rev; 2006; 7 Suppl 1():S125-7. PubMed ID: 16798536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manipulation of the immune response by Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus: consequences for tumor development.
    Ressing ME; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):379-80. PubMed ID: 18992819
    [No Abstract]   [Full Text] [Related]  

  • 40. Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines.
    Mohr CA; Cîcîn-Saîn L; Wagner M; Sacher T; Schnee M; Ruzsics Z; Koszinowski UH
    Int J Med Microbiol; 2008 Jan; 298(1-2):115-25. PubMed ID: 17702650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.